← Back to Search

Other

Continuous Positive Airway Pressure for Oropharyngeal Dysphagia

N/A

Waitlist Available

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during vfse (1 day)

Awards & highlights

Study Summary

This trial will test whether CPAP can help patients who had a total laryngectomy and are having trouble swallowing.

Eligible Conditions

Oropharyngeal Dysphagia
Laryngectomy

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during vfse (1 day)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during vfse (1 day)

This trial's timeline: 3 weeks for screening, Varies for treatment, and during vfse (1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Oropharyngeal and hypopharyngeal transit times

Secondary outcome measures

Pharyngeal Constriction Ratio (PCR)

Side effects data

From 2014 Phase 2 trial • 53 Patients • NCT01187771

32%

Respiratory tract infections

21%

Drowsy driving

18%

Injuries NEC

14%

Aural disorders NEC

14%

Epidermal and dermal conditions

11%

Gastrointestinal signs and symptoms

11%

Joint disorders

Upper respiratory tract disorders (excl infections)

Headaches

Gallbladder disorders

Tendon, ligament and cartilage disorders

Female reproductive tract infections and inflammations

Respiratory disorders NEC

Anxiety disorders and symptoms

Suicidal and self-injurious behaviors NEC

Gastrointestinal infections

Gastrointestinal motility

Procedural related injuries and complicatins NEC

Glucose metabolism disorders

Genitourinary tract disorders NEC

Medication errors

Bone disorders (excl congenital and fractures)

Ocular infections, irritations and inflammations

Diverticular disorders

Bone and joint injuries

Muscle disorders

Musculoskeletal and connective tissue disorders NEC

Coronary artery disrders

Urinary tract signs and symptoms

Demyelinating disorders

Depressed mood disorders and disturbances

Mood disorders and disturbances NEC

Skin and subcutaneous tissue infections and infestations

100%

80%

60%

40%

20%

Study treatment Arm

Laparoscopic Gastric Banding

Continuous Positive Airway Pressure

Trial Design

1Treatment groups

Experimental Treatment

Group I: Continue Positive Airway PressureExperimental Treatment1 Intervention

Continue Positive Airway Pressure during VFSE

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Continuous Positive Airway Pressure

2016

Completed Phase 3

~1720

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor

914 Previous Clinical Trials

4,720,834 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are actively engaged in the experiment?

"Right. According to the details published on clinicaltrials.gov, enrollment for this medical trial is actively in progress; it was initially posted on June 27th 2016 and its most recent update was January 26th 2022. Only 10 participants are needed from a single site."

Answered by AI

Are current participants being enrolled in this research?

"Affirmative. According to clinicaltrials.gov, this experiment is recruiting participants who are willing to take part in the trial. This study was posted on June 27th 2016 and has been updated as recently as January 26th 2022; 10 volunteers from one site need to be recruited for participation purposes."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

CPAP to Improve Swallow Function Post Total Laryngectomy

2016. "CPAP to Improve Swallow Function Post Total Laryngectomy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03328702.